Applied Molecular Transport - Pouchitis
A Combined Phase 2/3 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis
- AMT-101 is orally administered
- Males and females 18-75 with an IPAA for UC completed 1 year prior to screening
- Recurrent or chronic antibiotic resistant Pouchitis with >/= 2 episodes of pouchitis within 1 year prior to screening treated with antibiotics or maintenance antibiotic therapy taken continuously for >= 4 weeks immediately prior to the screening endoscopy
- Can be on stable doses of 5-ASA < 4.8 g/day, Steroids < 20mg (not budesonide)
If you are interested in participating in clinical studies, please send an email to email@example.com.